These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1680875)

  • 41. Something's burning.
    Hensrud DD
    Fortune; 2002 Jul; 146(1):150. PubMed ID: 12119728
    [No Abstract]   [Full Text] [Related]  

  • 42. Treating gastroesophageal reflux disease.
    Long K; Long R
    Nurse Pract Forum; 1994 Jun; 5(2):63-4. PubMed ID: 7912126
    [No Abstract]   [Full Text] [Related]  

  • 43. Helicobacter pylori-negative gastritis in erosive esophagitis, nonerosive reflux disease or functional dyspepsia patients.
    Peura DA; Haber MM; Hunt B; Atkinson S
    J Clin Gastroenterol; 2010 Mar; 44(3):180-5. PubMed ID: 19687753
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytomegalovirus esophagitis with symptoms of gastroesophageal reflux disease in a kidney transplant recipient.
    Chen YJ; Huang HC; Chen TC; Cheng HT
    Kaohsiung J Med Sci; 2020 Oct; 36(10):859-860. PubMed ID: 32671960
    [No Abstract]   [Full Text] [Related]  

  • 45. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management strategies for gastroesophageal reflux disease.
    Bak YT
    J Gastroenterol Hepatol; 2004 Sep; 19 Suppl 3():S49-53. PubMed ID: 15324382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Gastroesophageal reflux disease and chest pain].
    Pellicano R; Oliaro E; Berrutti M; Ponzetto A; Rizzetto M
    Minerva Cardioangiol; 2001 Jun; 49(3):197-209. PubMed ID: 11382836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
    Scarpignato C
    Dig Liver Dis; 2005 Jul; 37(7):468-74. PubMed ID: 15893968
    [No Abstract]   [Full Text] [Related]  

  • 49. H2 antagonists in the treatment of reflux esophagitis: a critical analysis.
    Stalnikowicz-Darvasi R
    Am J Gastroenterol; 1989 Mar; 84(3):245-8. PubMed ID: 2563926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of gastroesophageal reflux disease: to step or not to step.
    McGuigan JE
    Am J Gastroenterol; 2001 Jun; 96(6):1679-81. PubMed ID: 11419813
    [No Abstract]   [Full Text] [Related]  

  • 51. The histamine H2 receptor antagonist lafutidine in Japanese patients with non-erosive reflux disease.
    Inamori M; Iida H; Hosono K; Endo H; Sakamoto Y; Takahashi H; Koide T; Tokoro C; Goto A; Abe Y; Hiratsuka N; Nakajima A; Fujita M
    Hepatogastroenterology; 2010; 57(104):1430-4. PubMed ID: 21443098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Gastroesophageal reflux. To operate or to wait?].
    Morgante PE
    Acta Gastroenterol Latinoam; 1999; 29(5):345-7. PubMed ID: 10668073
    [No Abstract]   [Full Text] [Related]  

  • 53. Current medical and surgical treatment options for gastroesophageal reflux disease.
    Wo JM; Wilson MA
    J Ky Med Assoc; 2000 Nov; 98(11):482-9. PubMed ID: 11105473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Esophageal motor function and gastro-esophageal reflux esophagitis].
    Monés Xiol J
    Rev Esp Enferm Dig; 1998 Mar; 90(3):141-4. PubMed ID: 9595934
    [No Abstract]   [Full Text] [Related]  

  • 55. [Asthma and gastroesophageal reflux. Outcome of asthma after longterm medical treatment of the reflux].
    Ojeda Casas JA; García Ara MC; Martín Muñoz F; Díaz Pena JM; Añibarro Bausera B; Escobar Castro H
    An Esp Pediatr; 1990 Oct; 33(4):325-33. PubMed ID: 1980581
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acid inhibition and gastroesophageal reflux disease.
    Sachs G
    Yale J Biol Med; 1999; 72(2-3):227-9. PubMed ID: 10780585
    [No Abstract]   [Full Text] [Related]  

  • 58. [Comparison of the effects of Rocgel and anti-H2 on the symptomatology of gastroesophageal reflux without esophagitis].
    Houcke P; Maffioli C; Corallo J; Bouxin-Sauzet A; Martin AL
    Ann Gastroenterol Hepatol (Paris); 1995 Sep; 31(4):264-7. PubMed ID: 7486823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The treatment of gastroesophageal reflux disease.
    Kaplan B; Koppelo KL
    W V Med J; 1994 Dec; 90(12):510-7. PubMed ID: 7863640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of reflux esophageal disease.
    Robinson MG
    Am J Med; 1984 Nov; 77(5B):106-10. PubMed ID: 6150637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.